Below is this week’s summary of pending state legislation and tips to help you become involved in changing the laws in your state.

Illinois: Senate Bill 2865, which seeks to allow for the therapeutic use of cannabis for qualified patients, awaits action by the full Senate. This bill was recently amended to address concerns voiced by some of the Illinois law enforcement community. Illinois NORML supporters are urged to contact their state senator in support of SB 2865 through NORML’s online advocacy system.

Minnesota: Medical cannabis legislation is anticipated to go before the full House for a floor vote imminently, and if approved there, to the Governor’s desk. This legislation would ensure that medical marijuana patients in Minnesota would no longer have to fear arrest or prosecution from state law enforcement. However, Governor Pawlenty has indicated that he intends to veto this bill if it gets to his desk. You can view an ad urging Governor Pawlenty to rethink his position here. Minnesotans are strongly encouraged to urge their Representatives and the Governor to support these bills via NORML’s online advocacy system.

Hawaii: House Bill 2675, which would establish a legislative medical marijuana task force in Hawaii, is now before the governor. If signed into law, this task force would examine issues regarding adequate supplies of medical marijuana for qualified patients, distinguishing between mature and immature plants under current law, the feasibility of constructing secure growing facilities for medical marijuana patients to use to produce their medicine, and study inter-island travel issues related to medical marijuana. Hawaiian supporters can email their state senators via NORML’s online advocacy system.

Vermont: The Vermont Senate is expected to vote on House Bill 267, which would define industrial hemp as an “agricultural product” and establish regulations for its production by state-licensed farmers. If approved, Vermont will join more than a dozen states that have enacted laws or resolutions endorsing the study and/or production of industrial hemp. Vermont NORML supporters are strongly encouraged to send their state senator a prewritten letter urging passage of HB 267 via NORML’s online advocacy system.

New Hampshire: NORML is disheartened to announce that the New Hampshire Senate has defeated House Bill 1623, which would have decriminalized minor marijuana possession, in a voice vote this week. The Senate vote, which was not unexpected, followed weeks of veto threats from Governor John Lynch. The measure had previously passed the House by a vote of 193 to 141. NORML would like to take this time to thank NORML supporters who contacted their House Representatives in support of HB 1623. Your efforts made a huge difference in persuading the House to pass this vital piece of legislation. To remain involved in cannabis law reform efforts in New Hampshire, please visit: http://nhcommonsense.org.

Timothy Garon is dead. Why did he die?

The medical records will show that he died due to complications associated with massive liver failure. He would have likely survived longer if he received a timely organ transplant but was denied access because he followed his physician’s recommendation, used medical cannabis during his treatments for liver disease, therefore testing positive for THC metabolites and rather than receive the gift of a potentially longer life—instead doctors at the University of Washington deferred to federal prohibition laws and mores, handing Tim a death sentence.

There are no pharmacological or physiological reasons why Tim Garon, or any medical marijuana patient, should logically be denied access to life-saving or life-enhancing organ transplants.

In my view, commonsense and humanity were completely lacking here on the part of the doctors who denied Tim and his family a chance at a continued life together.

Full Story

A funny thing happens when the US government begrudgingly allows for double-blind, placebo-controlled clinical trials evaluating the therapeutic efficacy of inhaled cannabis.  

Investigators discover time after time that it works! 

Here are the results from the latest study, conducted at California’s Center for Medical Cannabis Research.   

Low-dose pot eases pain while keeping mind clear
via Reuters News Wire

NEW YORK (Reuters Health) — Giving carefully calibrated doses of smoked marijuana to people with neuropathic pain, which can be difficult-to-treat and extremely painful, can ease their pain without clouding their minds, California researchers report.

Read the full story here. 

Unfortunately, according to recently released legal filings, fewer than 20 investigators in the United States currently possess federal approval to conduct legal clinical research on whole smoked cannabis. (Not surprisingly, most of these researchers are conducting trials that seek to assess the potential physical and mental harms allegedly associated with the drug.) In addition, state funding for the CMCR — which has backed virtually all of the medical cannabis research conducted over the past several years — has dried up and no new appropriations are likely.

Of course, federal officials could readily step in with grant money to keep this important clinical research going — after all, just last month the US National Institute on Drug Abuse announced that it would be spending millions to establish the first-ever ‘Center on Cannabis Addiction‘ — but, needless to say, I’m not holding my breath.